{"id":94524,"date":"2026-08-05T11:37:54","date_gmt":"2026-08-05T02:37:54","guid":{"rendered":"https:\/\/japanir.jp\/en\/ir\/2395-20260805-03_wp_earnings_guidance\/"},"modified":"2026-08-05T11:37:54","modified_gmt":"2026-08-05T02:37:54","slug":"2395-20260805-03_wp_earnings_guidance","status":"publish","type":"ir_release","link":"https:\/\/japanir.jp\/en\/company\/company-2395\/ir\/2395-20260805-03_wp_earnings_guidance\/","title":{"rendered":"Notice Regarding Revisions to Consolidated Earnings Forecast for the Second Quarter of the Fiscal Year Ending March 2027"},"content":{"rendered":"<p>Revised the consolidated earnings forecast for the second quarter of the fiscal year ending March 2027. Net sales revised up from 16,596 million yen to 17,154 million yen (+558 million yen, +3.4%), operating income revised up from 463 million yen to 1,240 million yen (+777 million yen, +167.8%), ordinary income revised up from 1,948 million yen to 2,988 million yen (+1,040 million yen, +53.4%), and net income attributable to owners of the parent revised up from 1,167 million yen to 1,917 million yen (+750 million yen, +64.3%). The principal drivers are the steady progress of the CRO business, a delay in recognizing expenses in the TR business in the second half, and foreign exchange gains (172 million yen).<\/p>\n","protected":false},"comment_status":"open","ping_status":"closed","template":"","meta":{"Ticker":"","DATE":"","longName":"","company_name_ja":"","fullTimeEmployees":0,"address":"","phone":"","website":"","industry":"","sector":"","regularMarketPrice":0,"financialCurrency":"","marketCap":0,"fiftyTwoWeekLow":0,"fiftyTwoWeekHigh":0,"epsTrailingTwelveMonths":0,"epsForward":0,"bookValue":0,"totalRevenue":0,"OperatingIncome":0,"operatingMargins":0,"NetIncome":0,"profitMargins":0,"ebitda":0,"trailingPE":0,"forwardPE":0,"priceToBook":0,"returnOnEquity":0,"recommendationMean":0,"recommendationKey":"","targetMeanPrice":0,"numberOfAnalystOpinions":0,"analyst_earnings_data":"","dividendRate":0,"dividendYield":0,"payoutRatio":0,"totalEsg":0,"environmentScore":0,"socialScore":0,"governanceScore":0,"title":"","providerPublishTime":"","link":"","longBusinessSummary":"","longBusinessSummary_ja":"","quarterly_revenue":0,"quarterly_net_income":0,"quarterly_operating_profit":0,"enterprise_value":0,"company_officer_1_name":"","company_officer_1_title":"","company_officer_2_name":"","company_officer_2_title":"","company_officer_3_name":"","company_officer_3_title":"","company_officer_4_name":"","company_officer_4_title":"","company_officer_5_name":"","company_officer_5_title":"","company_officers_update_time":"","get_dividend_history_year1":0,"get_dividend_history_year2":0,"get_dividend_history_year3":0,"get_dividend_history_year4":0,"get_dividend_history_year5":0,"get_dividend_history_year6":0,"get_dividend_history_year7":0,"get_dividend_history_year8":0,"get_dividend_history_year9":0,"get_dividend_history_year10":0,"site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","theme-transparent-header-meta":"","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"jir_stock_code":"2395","jir_company_name":"NIPPON STEEL SCIENCE CORPORATION","jir_importance":"\u2605\u2605\u2605\u2605\u2606","jir_publication_date":"2026-08-05","jir_source_link":"https:\/\/japanir.jp\/wp-content\/uploads\/2026\/08\/2395-20260805-03.pdf","jir_short_summary":"Revised the consolidated earnings forecast for the second quarter of the fiscal year ending March 2027. Net sales revised up from 16,596 million yen to 17,154 million yen (+558 million yen, +3.4%), operating income revised up from 463 million yen to 1,240 million yen (+777 million yen, +167.8%), ordinary income revised up from 1,948 million yen to 2,988 million yen (+1,040 million yen, +53.4%), and net income attributable to owners of the parent revised up from 1,167 million yen to 1,917 million yen (+750 million yen, +64.3%). The principal drivers are the steady progress of the CRO business, a delay in recognizing expenses in the TR business in the second half, and foreign exchange gains (172 million yen).","jir_summary":"### Overview of the earnings revision\nWe revised the consolidated earnings forecast for the second quarter (interim period) of the fiscal year ending March 2027, as announced on May 11, 2026, for the period from April 1, 2026 to September 30, 2026. Net sales are expected to exceed the previous forecast owing to the steady progress of the CRO business, and operating income, ordinary income, and net income are all expected to rise significantly. Additionally, foreign exchange gains recorded in the first quarter contributed to the revision.\n\n### Outlook and key factors\nThe main factors behind the revision are the stable growth of the CRO business, expected delays in expense recognition in the TR business in the second half, and foreign exchange gains of 172 million yen in the first quarter. The foreign exchange assumption for the fiscal year ending March 2027 remains at 150.00 yen\/USD. Actual results may fluctuate depending on future exchange movements and progress across each business.","jir_financial_highlights":"Net sales: 16,596 \u767e\u4e07\u5186 \u2192 17,154 \u767e\u4e07\u5186 (+558 \u767e\u4e07\u5186\uff08+3.4%\uff09)\nOperating income: 463 \u767e\u4e07\u5186 \u2192 1,240 \u767e\u4e07\u5186 (+777 \u767e\u4e07\u5186\uff08+167.8%\uff09)\nOrdinary income: 1,948 \u767e\u4e07\u5186 \u2192 2,988 \u767e\u4e07\u5186 (+1,040 \u767e\u4e07\u5186\uff08+53.4%\uff09)\nNet income attributable to owners of the parent: 1,167 \u767e\u4e07\u5186 \u2192 1,917 \u767e\u4e07\u5186 (+750 \u767e\u4e07\u5186\uff08+64.3%\uff09)\nNet income per share: 28.03 \u5186 \u2192 46.04 \u5186 (+18.01 \u5186)","jir_category":"","jir_hashtags":"#\u65b0\u65e5\u9244\u79d1\u5b78\u682a\u5f0f\u4f1a\u793e, # earnings_guidance, #\u65e5\u672c\u682a","jir_key_figures":"Net sales: 16,596\u767e\u4e07\u5186\u219217,154\u767e\u4e07\u5186\uff08+3.4%\uff09\nOperating income: 463\u767e\u4e07\u5186\u21921,240\u767e\u4e07\u5186\uff08+167.8%\uff09\nOrdinary income: 1,948\u767e\u4e07\u5186\u21922,988\u767e\u4e07\u5186\uff08+53.4%\uff09","jir_meta_title":"\u3010\u65b0\u65e5\u9244\u79d1\u5b78\u682a\u5f0f\u4f1a\u793e\u3011Upward Revision of Earnings Forecast\uff5cSecond Quarter of the Fiscal Year Ending March 2027","jir_meta_description":"NIPPON STEEL SCIENCE reports an upward revision of the earnings forecast for the second quarter of the fiscal year ending March 2027. Substantial improvements expected in net sales, operating income, and net income. Factors include strong CRO business performance and foreign exchange gains. Please refer to the IR release for details.","jir_og_title":"NIPPON STEEL SCIENCE Upward Revision of Earnings Forecast\uff5cQ2 FY2027","jir_og_description":"Against the backdrop of solid CRO performance and foreign exchange gains, the earnings forecast for Q2 FY2027 has been significantly revised upward. Includes detailed figures for sales and profits.","jir_og_image_url":"\/assets\/og\/company-general_ir.jpg","jir_chart_data_collection":"[]","ir_related_company":17048,"ir_release_date":"","ir_type":"","ir_is_new":false,"ir_document_url":"","jir_ir_type":"earnings_guidance","footnotes":""},"sector":[],"importance":[],"class_list":["post-94524","ir_release","type-ir_release","status-publish","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v24.7 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Notice Regarding Revisions to Consolidated Earnings Forecast for the Second Quarter of the Fiscal Year Ending March 2027 - Japan IR<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/japanir.jp\/en\/company\/company-2395\/ir\/2395-20260805-03_wp_earnings_guidance\/\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/japanir.jp\/en\/company\/company-2395\/ir\/2395-20260805-03_wp_earnings_guidance\/\",\"url\":\"https:\/\/japanir.jp\/en\/company\/company-2395\/ir\/2395-20260805-03_wp_earnings_guidance\/\",\"name\":\"Notice Regarding Revisions to Consolidated Earnings Forecast for the Second Quarter of the Fiscal Year Ending March 2027 - Japan IR\",\"isPartOf\":{\"@id\":\"https:\/\/japanir.jp\/en\/#website\"},\"datePublished\":\"2026-08-05T02:37:54+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/japanir.jp\/en\/company\/company-2395\/ir\/2395-20260805-03_wp_earnings_guidance\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/japanir.jp\/en\/company\/company-2395\/ir\/2395-20260805-03_wp_earnings_guidance\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/japanir.jp\/en\/company\/company-2395\/ir\/2395-20260805-03_wp_earnings_guidance\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/japanir.jp\/en\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Notice Regarding Revisions to Consolidated Earnings Forecast for the Second Quarter of the Fiscal Year Ending March 2027\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/japanir.jp\/en\/#website\",\"url\":\"https:\/\/japanir.jp\/en\/\",\"name\":\"Japan IR\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/japanir.jp\/en\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Notice Regarding Revisions to Consolidated Earnings Forecast for the Second Quarter of the Fiscal Year Ending March 2027 - Japan IR","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/japanir.jp\/en\/company\/company-2395\/ir\/2395-20260805-03_wp_earnings_guidance\/","schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/japanir.jp\/en\/company\/company-2395\/ir\/2395-20260805-03_wp_earnings_guidance\/","url":"https:\/\/japanir.jp\/en\/company\/company-2395\/ir\/2395-20260805-03_wp_earnings_guidance\/","name":"Notice Regarding Revisions to Consolidated Earnings Forecast for the Second Quarter of the Fiscal Year Ending March 2027 - Japan IR","isPartOf":{"@id":"https:\/\/japanir.jp\/en\/#website"},"datePublished":"2026-08-05T02:37:54+00:00","breadcrumb":{"@id":"https:\/\/japanir.jp\/en\/company\/company-2395\/ir\/2395-20260805-03_wp_earnings_guidance\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/japanir.jp\/en\/company\/company-2395\/ir\/2395-20260805-03_wp_earnings_guidance\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/japanir.jp\/en\/company\/company-2395\/ir\/2395-20260805-03_wp_earnings_guidance\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/japanir.jp\/en\/"},{"@type":"ListItem","position":2,"name":"Notice Regarding Revisions to Consolidated Earnings Forecast for the Second Quarter of the Fiscal Year Ending March 2027"}]},{"@type":"WebSite","@id":"https:\/\/japanir.jp\/en\/#website","url":"https:\/\/japanir.jp\/en\/","name":"Japan IR","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/japanir.jp\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"}]}},"related_company_data":{"id":"17048","title":"SHIN NIPPON BIOMEDICAL LABORATO","ticker":"2395"},"_links":{"self":[{"href":"https:\/\/japanir.jp\/en\/wp-json\/wp\/v2\/ir-release\/94524","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/japanir.jp\/en\/wp-json\/wp\/v2\/ir-release"}],"about":[{"href":"https:\/\/japanir.jp\/en\/wp-json\/wp\/v2\/types\/ir_release"}],"replies":[{"embeddable":true,"href":"https:\/\/japanir.jp\/en\/wp-json\/wp\/v2\/comments?post=94524"}],"version-history":[{"count":0,"href":"https:\/\/japanir.jp\/en\/wp-json\/wp\/v2\/ir-release\/94524\/revisions"}],"wp:attachment":[{"href":"https:\/\/japanir.jp\/en\/wp-json\/wp\/v2\/media?parent=94524"}],"wp:term":[{"taxonomy":"sector","embeddable":true,"href":"https:\/\/japanir.jp\/en\/wp-json\/wp\/v2\/sector?post=94524"},{"taxonomy":"importance","embeddable":true,"href":"https:\/\/japanir.jp\/en\/wp-json\/wp\/v2\/importance?post=94524"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}